D
Insmed Incorporated
INSM
$64.97
-$3.12-4.58%
D
Sell
5/5/2023Upgraded
Insmed Incorporated (INSM) was upgraded to D- from E+ on 5/5/2023 due to an increase in the valuation index and growth index. Total revenue increased 9.97% from $59.3M to $65.21M, and earnings per share increased from -$1.2067 to -$1.1717.
Insmed Incorporated (INSM) was upgraded to D- from E+ on 5/5/2023 due to an increase in the valuation index and growth index. Total revenue increased 9.97% from $59.3M to $65.21M, and earnings per share increased from -$1.2067 to -$1.1717.
E
Sell
3/14/2023Downgrade
Insmed Incorporated (INSM) was downgraded to E+ from D on 3/14/2023 due to a decline in the valuation index, growth index and volatility index. EBIT declined 25.16% from -$122.46M to -$153.28M, operating cash flow declined 14.83% from -$89.83M to -$103.15M, and total revenue declined 12.45% from $67.73M to $59.3M.
Insmed Incorporated (INSM) was downgraded to E+ from D on 3/14/2023 due to a decline in the valuation index, growth index and volatility index. EBIT declined 25.16% from -$122.46M to -$153.28M, operating cash flow declined 14.83% from -$89.83M to -$103.15M, and total revenue declined 12.45% from $67.73M to $59.3M.
D
Sell
2/23/2023Upgraded
Insmed Incorporated (INSM) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index.
Insmed Incorporated (INSM) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index.
D
Sell
2/8/2023Downgrade
Insmed Incorporated (INSM) was downgraded to D- from D on 2/8/2023 due to a significant decline in the solvency index and total return index. The quick ratio declined from 5.13 to 3.93.
Insmed Incorporated (INSM) was downgraded to D- from D on 2/8/2023 due to a significant decline in the solvency index and total return index. The quick ratio declined from 5.13 to 3.93.
D
Sell
5/16/2022Upgraded
Insmed Incorporated (INSM) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
Insmed Incorporated (INSM) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
E
Sell
5/13/2022Downgrade
Insmed Incorporated (INSM) was downgraded to E+ from D on 5/13/2022 due to a noticeable decline in the solvency index, volatility index and valuation index. Debt to equity increased from 1.41 to 6.61, and the quick ratio declined from 5.48 to 5.28.
Insmed Incorporated (INSM) was downgraded to E+ from D on 5/13/2022 due to a noticeable decline in the solvency index, volatility index and valuation index. Debt to equity increased from 1.41 to 6.61, and the quick ratio declined from 5.48 to 5.28.
D
Sell
5/4/2022Upgraded
Insmed Incorporated (INSM) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index and valuation index.
Insmed Incorporated (INSM) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index and valuation index.
E
Sell
5/1/2022Downgrade
Insmed Incorporated (INSM) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index and total return index.
Insmed Incorporated (INSM) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index and total return index.
D
Sell
4/21/2022Upgraded
Insmed Incorporated (INSM) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index.
Insmed Incorporated (INSM) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index.
E
Sell
4/20/2022Downgrade
Insmed Incorporated (INSM) was downgraded to E+ from D on 4/20/2022 due to a noticeable decline in the total return index, volatility index and growth index. Operating cash flow declined 11.51% from -$75.45M to -$84.13M, and EBIT declined 5.62% from -$94.72M to -$100.04M.
Insmed Incorporated (INSM) was downgraded to E+ from D on 4/20/2022 due to a noticeable decline in the total return index, volatility index and growth index. Operating cash flow declined 11.51% from -$75.45M to -$84.13M, and EBIT declined 5.62% from -$94.72M to -$100.04M.
D
Sell
11/23/2021Upgraded
Insmed Incorporated (INSM) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index.
Insmed Incorporated (INSM) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index.
D
Sell
11/8/2021Downgrade
Insmed Incorporated (INSM) was downgraded to D- from D on 11/8/2021 due to a decline in the efficiency index and growth index. EBIT declined 6.95% from -$88.57M to -$94.72M, and total capital declined 1.63% from $1.12B to $1.11B.
Insmed Incorporated (INSM) was downgraded to D- from D on 11/8/2021 due to a decline in the efficiency index and growth index. EBIT declined 6.95% from -$88.57M to -$94.72M, and total capital declined 1.63% from $1.12B to $1.11B.
D
Sell
11/25/2019Upgraded
Insmed Incorporated (INSM) was upgraded to D from D- on 11/25/2019 due to a substantial increase in the growth index, solvency index and efficiency index. Operating cash flow increased 34.56% from -$80.03M to -$52.37M, total revenue increased 29.74% from $29.97M to $38.89M, and earnings per share increased from -$0.8131 to -$0.68.
Insmed Incorporated (INSM) was upgraded to D from D- on 11/25/2019 due to a substantial increase in the growth index, solvency index and efficiency index. Operating cash flow increased 34.56% from -$80.03M to -$52.37M, total revenue increased 29.74% from $29.97M to $38.89M, and earnings per share increased from -$0.8131 to -$0.68.
D
Sell
1/8/2019Downgrade
Insmed Incorporated (INSM) was downgraded to D- from D on 1/8/2019 due to a decline in the total return index, valuation index and volatility index.
Insmed Incorporated (INSM) was downgraded to D- from D on 1/8/2019 due to a decline in the total return index, valuation index and volatility index.
D
Sell
12/20/2018Upgraded
Insmed Incorporated (INSM) was upgraded to D from D- on 12/20/2018 due to an increase in the valuation index and efficiency index.
Insmed Incorporated (INSM) was upgraded to D from D- on 12/20/2018 due to an increase in the valuation index and efficiency index.
D
Sell
8/3/2018Downgrade
Insmed Incorporated (INSM) was downgraded to D- from D on 8/3/2018 due to a decline in the solvency index, valuation index and efficiency index. The quick ratio declined from 19.73 to 13.9, debt to equity increased from 0.7 to 0.83, and net income declined 11.55% from -$68.52M to -$76.44M.
Insmed Incorporated (INSM) was downgraded to D- from D on 8/3/2018 due to a decline in the solvency index, valuation index and efficiency index. The quick ratio declined from 19.73 to 13.9, debt to equity increased from 0.7 to 0.83, and net income declined 11.55% from -$68.52M to -$76.44M.
D
Sell
5/3/2018Upgraded
Insmed Incorporated (INSM) was upgraded to D from D- on 5/3/2018 due to an increase in the growth index, valuation index and solvency index. The quick ratio increased from 8.54 to 19.73, and EBIT increased 3.98% from -$65.35M to -$62.75M.
Insmed Incorporated (INSM) was upgraded to D from D- on 5/3/2018 due to an increase in the growth index, valuation index and solvency index. The quick ratio increased from 8.54 to 19.73, and EBIT increased 3.98% from -$65.35M to -$62.75M.
D
Sell
2/28/2018Downgrade
Insmed Incorporated (INSM) was downgraded to D- from D on 2/28/2018 due to a significant decline in the total return index, solvency index and growth index. EBIT declined 48.25% from -$44.08M to -$65.35M, the quick ratio declined from 14.97 to 8.54, and operating cash flow declined 26.11% from -$38.24M to -$48.22M.
Insmed Incorporated (INSM) was downgraded to D- from D on 2/28/2018 due to a significant decline in the total return index, solvency index and growth index. EBIT declined 48.25% from -$44.08M to -$65.35M, the quick ratio declined from 14.97 to 8.54, and operating cash flow declined 26.11% from -$38.24M to -$48.22M.
D
Sell
11/3/2017Upgraded
Insmed Incorporated (INSM) was upgraded to D from D- on 11/3/2017 due to a significant increase in the total return index, efficiency index and volatility index. Total capital increased 243.84% from $138.64M to $476.69M.
Insmed Incorporated (INSM) was upgraded to D from D- on 11/3/2017 due to a significant increase in the total return index, efficiency index and volatility index. Total capital increased 243.84% from $138.64M to $476.69M.
D
Sell
12/22/2016Downgrade
Insmed Incorporated (INSM) was downgraded to D- from D on 12/22/2016 due to a decline in the valuation index, total return index and volatility index.
Insmed Incorporated (INSM) was downgraded to D- from D on 12/22/2016 due to a decline in the valuation index, total return index and volatility index.
D
Sell
11/10/2016Upgraded
Insmed Incorporated (INSM) was upgraded to D from D- on 11/10/2016 due to an increase in the volatility index and total return index.
Insmed Incorporated (INSM) was upgraded to D from D- on 11/10/2016 due to an increase in the volatility index and total return index.
D
Sell
11/3/2016Downgrade
Insmed Incorporated (INSM) was downgraded to D- from D on 11/3/2016 due to a decline in the volatility index.
Insmed Incorporated (INSM) was downgraded to D- from D on 11/3/2016 due to a decline in the volatility index.
D
Sell
10/3/2016Upgraded
Insmed Incorporated (INSM) was upgraded to D from D- on 10/3/2016 due to a noticeable increase in the solvency index and volatility index.
Insmed Incorporated (INSM) was upgraded to D from D- on 10/3/2016 due to a noticeable increase in the solvency index and volatility index.
D
Sell
7/26/2016Downgrade
Insmed Incorporated (INSM) was downgraded to D- from D on 7/26/2016 due to a major decline in the total return index, volatility index and efficiency index. Total capital declined 8.78% from $336.84M to $307.25M, and net income declined 7.32% from -$31.25M to -$33.53M.
Insmed Incorporated (INSM) was downgraded to D- from D on 7/26/2016 due to a major decline in the total return index, volatility index and efficiency index. Total capital declined 8.78% from $336.84M to $307.25M, and net income declined 7.32% from -$31.25M to -$33.53M.
D
Sell
2/16/2016Downgrade
Insmed Incorporated (INSM) was downgraded to D from D+ on 2/16/2016 due to a significant decline in the volatility index and total return index.
Insmed Incorporated (INSM) was downgraded to D from D+ on 2/16/2016 due to a significant decline in the volatility index and total return index.
D
Sell
11/6/2015Downgrade
Insmed Incorporated (INSM) was downgraded to D+ from C- on 11/6/2015 due to a large decline in the total return index, growth index and solvency index. The quick ratio declined from 7.78 to 6.66, and operating cash flow declined 0.87% from -$24.24M to -$24.03M.
Insmed Incorporated (INSM) was downgraded to D+ from C- on 11/6/2015 due to a large decline in the total return index, growth index and solvency index. The quick ratio declined from 7.78 to 6.66, and operating cash flow declined 0.87% from -$24.24M to -$24.03M.
C
Hold
9/30/2015Upgraded
Insmed Incorporated (INSM) was upgraded to C- from D+ on 9/30/2015 due to an increase in the valuation index.
Insmed Incorporated (INSM) was upgraded to C- from D+ on 9/30/2015 due to an increase in the valuation index.
D
Sell
8/7/2015Upgraded
Insmed Incorporated (INSM) was upgraded to D+ from D on 8/7/2015 due to a major increase in the total return index, growth index and efficiency index. Total capital increased 105.66% from $189.85M to $390.46M, EBIT increased 4.67% from -$26.71M to -$27.95M, and net income increased 4.52% from -$27.37M to -$28.61M.
Insmed Incorporated (INSM) was upgraded to D+ from D on 8/7/2015 due to a major increase in the total return index, growth index and efficiency index. Total capital increased 105.66% from $189.85M to $390.46M, EBIT increased 4.67% from -$26.71M to -$27.95M, and net income increased 4.52% from -$27.37M to -$28.61M.
D
Sell
5/8/2015Downgrade
Insmed Incorporated (INSM) was downgraded to D from D+ on 5/8/2015 due to a noticeable decline in the growth index, valuation index and efficiency index. Total capital declined 10.06% from $211.09M to $189.85M.
Insmed Incorporated (INSM) was downgraded to D from D+ on 5/8/2015 due to a noticeable decline in the growth index, valuation index and efficiency index. Total capital declined 10.06% from $211.09M to $189.85M.
D
Sell
11/10/2014Upgraded
Insmed Incorporated (INSM) was upgraded to D+ from D on 11/10/2014 due to an increase in the valuation index, solvency index and efficiency index. The quick ratio increased from 3.79 to 7.86, total capital increased 66.86% from $131.36M to $219.17M, and debt to equity declined from 0.18 to 0.1.
Insmed Incorporated (INSM) was upgraded to D+ from D on 11/10/2014 due to an increase in the valuation index, solvency index and efficiency index. The quick ratio increased from 3.79 to 7.86, total capital increased 66.86% from $131.36M to $219.17M, and debt to equity declined from 0.18 to 0.1.
D
Sell
6/23/2014Downgrade
Insmed Incorporated (INSM) was downgraded to D from D+ on 6/23/2014 due to a large decline in the total return index, solvency index and efficiency index. The quick ratio declined from 6.92 to 5.06, net income declined 11.82% from -$16.21M to -$14.3M, and debt to equity increased from 0.14 to 0.15.
Insmed Incorporated (INSM) was downgraded to D from D+ on 6/23/2014 due to a large decline in the total return index, solvency index and efficiency index. The quick ratio declined from 6.92 to 5.06, net income declined 11.82% from -$16.21M to -$14.3M, and debt to equity increased from 0.14 to 0.15.
NASDAQ
04/08/2025 4:00PM Eastern
Quotes delayed
